Synthesis report on Biotech National and EU Policies AFIBIO Network (Access to Finance in The Biotechnology Sector), 2007 Download   The approach This review was prepared by the Institute of Baltic Studies (IBS) in the framework of the AFIBIO project based on various national policy documents on biotech funding identified by the members o...

Overview of the Biotech–Health Sector in Europe Project: AFIBIO (Access to Finance in the Biotech Sector) Workpackage 1 – Identification and analysis of the biotech sector specificities relevant to access to finance (2006) Download   Introduction The Workpackage 1 aims at a better and common understanding of biotech-health sector s...

'Networking INnovation actors in the medical device sector' 8.6% of GDP in Europe is spent on health, of which 6.4% is for medical technology. Although this expenditure delivers an exceptional return on investment, there is a need for continual innovation. Increasing patient treatment and operating costs mean that the commercial prospe...

Commercialisation of first-class research and the development of the European Biotech Healthcare sector are problematic especially in terms of unmet financial needs and poor cooperation between sector actors. The lack of early-stage risk capital severely hampers the formation of innovative start-up companies: Europe's start-ups need new forms...